Eurogin is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The burden of cervical cancer is disproportionately higher in Eastern and Central Europe than in other parts of Europe, both in terms of incidence and mortality.
The workshop will provide a detailed overview of the current status of cervical cancer prevention, management and treatment in 16 Eastern and Central European countries: Albania, Bosnia and Herzegovina, Bulgaria, Croatia, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia, and The Republic of North Macedonia.
In the first part latest available epidemiological data concerning burden of cervical cancer and other HPV-related cancers in the region will be presented followed by an overview of cervical cancer screening practices and their implementation as well as HPV vaccine implementation.
The second part will showcase country-specific exemplars (both positive and negative) of implementation of HPV vaccination as well as organized HPV-based cervical cancer screening programs in the region.
Third part will focus on treatment and clinical management of cervical cancer and high-grade cervical lesions with some country-specific exemplars.
Don't miss out on the the world’s leading international congress on HPV infection and associated cancers. See you in Vienna, March 18-21, 2026